Securities code: 603392 securities abbreviation: Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) Announcement No.: 2022-018
Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392)
Announcement of the resolution of the first extraordinary general meeting of shareholders in 2022
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents. Important content tips: whether there is a veto proposal at this meeting: none. The convening and attendance of the meeting
（1） Time of the general meeting of shareholders: February 7, 2022
（2） Venue of the general meeting of shareholders: conference room (III) of the company, No. 31, kekekeyuan Road, Changping District, Beijing ordinary shareholders attending the meeting and preferred shareholders who have restored their voting rights and their shares:
1. Number of shareholders and proxies attending the meeting 69
2. The total number of voting shares (shares) held by shareholders attending the meeting is 495839157
3. The number of voting shares held by shareholders attending the meeting accounts for the company’s voting shares
81.6814% of the total number of shares (%) (IV) whether the voting method complies with the provisions of the company law and the articles of association, the chairmanship of the general meeting, etc. The general meeting of shareholders was convened by the board of directors of the company and issued a notice, which was presided over by Mr. Qiu Zixin, chairman of the company. The voting method of the meeting is the combination of on-site and online voting. The convening and convening procedures, the qualifications of participants and voting procedures of the meeting comply with the provisions of the company law and the articles of association. （5） Attendance of directors, supervisors and Secretary of the board of directors of the company
1. 7 directors in office and 7 attendees;
2. There are 3 supervisors in office and 3 present;
3. Chairman Qiu Zixin (acting as secretary of the board of directors) attended the meeting; Li Shayan, deputy general manager, and Zhao Yiyong, chief financial officer, attended the meeting as nonvoting delegates; Chief engineer Li Yimin did not attend the meeting due to work reasons. 2、 Proposal deliberation (I) non cumulative voting proposal 1. Proposal Name: proposal on Amending the articles of Association
Result of deliberation: voting:
Agree against abstention
Types of shareholders
Proportion of votes (%)
A shares 492775004 99.3820 3056153 0.6163 8000 0.0017
（2） Explanation on the voting of proposals
The proposal discussed at this meeting is a special resolution proposal, which has been adopted by more than 2 / 3 of the voting rights held by shareholders and shareholders’ agents attending the general meeting of shareholders. 3、 Witness of lawyers 1. Law firm witnessed at the shareholders’ meeting: Beijing Zhonglun law firm
Lawyer: Zhang Jing, Li tomorrow 2. Lawyer’s Witness conclusion:
The witness lawyer believes that the convening and convening procedures, the qualifications of attendees, the qualifications of conveners, voting procedures and voting results of this meeting comply with the provisions of relevant laws, regulations, normative documents and the articles of association, and the voting results of this meeting are legal and valid. 4、 List of documents for future reference 1. Resolutions of the general meeting of shareholders signed and confirmed by the attending directors and recorders and stamped with the seal of the board of directors; 2. A legal opinion signed and sealed by the director of the witnessed law firm; 3. Other documents required by the exchange.
Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) February 8, 2022
